top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

68.41 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	141
Open	68.41
Bid (Size)	68.00 (100)
Ask (Size)	69.70 (100)
Prev. Close	68.41
Today's Range	68.41 - 68.41
52wk Range	47.50 - 82.22
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm

April 21, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

Via StockStory

3 Cash-Producing Stocks with Exciting Potential

April 10, 2026

Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain ...

Via StockStory

Performance

YTD	-2.7%	-2.7%
1 Month	+8.8%	+8.8%
3 Month	-2.9%	-2.9%
6 Month	+2.3%	+2.3%
1 Year	+19.4%	+19.4%

More News

2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore

April 09, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

April 08, 2026

Via StockStory

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

March 06, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Reports Mixed Q4 2025 Results with Revenue Beat and Unexpected Loss ↗

February 17, 2026

Via Chartmill

HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation ↗

February 17, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Growth and Technical Setup ↗

January 29, 2026

Via Chartmill

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

March 24, 2026

Via StockStory

2 Reasons to Like HALO (and 1 Not So Much)

February 24, 2026

Via StockStory

Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales

February 17, 2026

Via StockStory

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

Via StockStory

3 Small-Cap Stocks with Solid Fundamentals

February 08, 2026

Via StockStory

3 Growth Stocks Set to Flourish

February 01, 2026

Via StockStory

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

Via StockStory

Q3 Earnings Highs And Lows: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks

January 28, 2026

Via StockStory

HALO Stock Edges Up 3% On Upbeat Multi-Year Revenue Guidance, Surf Bio Acquisition ↗

January 28, 2026

Via Stocktwits

Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)

January 27, 2026

Via StockStory

Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks

January 25, 2026

Via StockStory

2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗

January 24, 2026

Via The Motley Fool

Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)

January 21, 2026

Via StockStory

Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

January 19, 2026

Via StockStory

Halozyme Therapeutics: A 6.3 Rating and a Future Full of Uncertainty ↗

January 19, 2026

Via The Motley Fool

Q3 Therapeutics Earnings: Halozyme Therapeutics (NASDAQ:HALO) Earns Top Marks

January 18, 2026

Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 68.41

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 04/21/26 04:00 PM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.74B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

bottom of page